Qingsong Niu
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
In silico validation of a new classifier, PCSCGier , for predicting recurrence-free survival in prostate cancer patients: Evidence from multiple datasets.
Journal: Clinical and translational medicine
Published: August 17, 2022
Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer.
Journal: Cancer cell international
Published: December 17, 2021
Establishment of a five-enzalutamide-resistance-related-gene-based classifier for recurrence-free survival predicting of prostate cancer.
Journal: Journal of cellular and molecular medicine
Published: November 17, 2021
CXCR3 antagonist AMG487 ameliorates experimental autoimmune prostatitis by diminishing Th1 cell differentiation and inhibiting macrophage M1 phenotypic activation.
Journal: The Prostate
Published: November 12, 2021
Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer.
Journal: Cancer management and research
Published: June 02, 2020
Laparoscopic ureterolithotomy, flexible ureteroscopic lithotripsy and percutaneous nephrolithotomy for treatment of upper urinary calculi in patients with autosomal dominant polycystic kidney disease.
Journal: Clinical and experimental nephrology
Published: November 25, 2019
Transparenchymal Renal Pelvis Injection of Recombinant Adeno-Associated Virus Serotype 9 Vectors Is a Practical Approach for Gene Delivery in the Kidney.
Journal: Human gene therapy methods
Published: November 21, 2018
Polymorphism of MMP-9 gene is not associated with the risk of urinary cancers: Evidence from an updated meta-analysis.
Journal: Pathology, research and practice
Published: August 03, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026